Capabilities
Active Pharmaceutical Ingredients
Product
Facilities
Finished Dose Formulations
Product
Facilities
Antimicrobial Solutions
Novel Medicine
Featured Portfolio
Antimicrobial Stewardship Program
Exblifep
Research
Fighting AMR
Fighting AMR
Antimicrobial Stewardships
Company
About us
Careers
Our thoughts
Investor
Contact
Contact
Stockexchanges
Amendment to the Code of practices and procedures for fair disclosure of Unpublished Price Sensitive Information
April 5, 2019
Certificate under Regulation 7(3) of the SEBI (LODR) Regulations,2015 for the half year ended March 31,2019
March 31, 2019
Regulation 13(3)-Statement of Investor complaints for the quarter ended March 31,2019
March 31, 2019
Certificate under Regulation 40(9) of the SEBI (LODR) Regulations,2015
March 31, 2019
Regulation 27(2)- Corporate Governance report-quarter ended March 31,2019
March 31, 2019
Reconciliation of Share Capital Audit report- quarter ended March 31,2019
March 31, 2019
Regulation 23(9) - Disclosure of Related Party transactions for the half year ended March 31,2019
March 31, 2019
Updates on meeting of Committee of Creditors-May 03,2019
March 3, 2019
Disclosure under Regulation 30 of the SEBI (LODR) Regulations,2015-March 01,2019
March 1, 2019
Intimation about meeting by the Resolution Professional – February 13,2019
February 13, 2019
Outcome of meeting convened by the Resolution Professional- February 13,2019
February 13, 2019
Outcome of meeting convened by the Resolution Professional-January 29,2019
January 29, 2019
Regulation 27(2)- Corporate Governance report-quarter ended December 31,2018
December 31, 2018
Disclosure of voting results pursuant to Regulation 44(3) of SEBI (LODR) Regulations,2015
December 13, 2018
Proceedings-25th Annual General Meeting-NSE Ltd and BSE Ltd
December 12, 2018
Newspaper advertisement of the 25th AGM, E-voting and Book closure- NSE Ltd
December 6, 2018
Previous
1
...
Next
28 / 36